BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 29228424)

  • 1. Comprehensive evaluation of serum circHAS2 as a novel diagnostic and prognostic biomarker for gastric cancer.
    Ma S; Yao Y; Xu Y; Zou M; Zhou M; Abudushalamu G; Chen Y; Cai S; Zhang C; Wu G
    Mol Carcinog; 2024 Jan; 63(1):94-105. PubMed ID: 37750590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHB2 promotes SHIP2 ubiquitination via the E3 ligase NEDD4 to regulate AKT signaling in gastric cancer.
    Xu L; Xiang W; Yang J; Gao J; Wang X; Meng L; Ye K; Zhao XH; Zhang XD; Jin L; Ye Y
    J Exp Clin Cancer Res; 2024 Jan; 43(1):17. PubMed ID: 38200519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma.
    Kang CY; Wang J; Axell-House D; Soni P; Chu ML; Chipitsyna G; Sarosiek K; Sendecki J; Hyslop T; Al-Zoubi M; Yeo CJ; Arafat HA
    J Gastrointest Surg; 2014 Jan; 18(1):7-15. PubMed ID: 24002763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mRNA of solute carrier family 22, member 17 (SLC22A17) plays the potential diagnostic and prognostic role in advantage non-small cell lung cancer patients.
    Qin W; Ding C; Peng F; Wang P
    Ann Biol Clin (Paris); 2024 Feb; 81(6):602-609. PubMed ID: 38391165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel tRNA-derived fragment tRF-17-18VBY9M works as a potential diagnostic biomarker for gastric cancer.
    Mao C; Zhang Z; Fang R; Yuan W; Wu Y; Cong H
    J Cancer Res Clin Oncol; 2024 May; 150(5):263. PubMed ID: 38767702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of plasma exosomal circLPAR1 in patients with gastric cancer and its clinical application value.
    Yang X; Xia J; Peng C; Cai W
    Am J Cancer Res; 2023; 13(9):4269-4276. PubMed ID: 37818058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-Specific Alteration and Prognostic Relationship of Serum Fumarate Hydratase Autoantibodies in Gastric Cancer.
    Sasajima N; Sumazaki M; Oshima Y; Ito M; Yajima S; Takizawa H; Wang H; Li SY; Zhang BS; Yoshida Y; Hiwasa T; Shimada H
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of circulating lncRNA H19 in gastric cancer.
    Yörüker EE; Keskin M; Kulle CB; Holdenrieder S; Gezer U
    Biomed Rep; 2018 Aug; 9(2):181-186. PubMed ID: 30083318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of serum circulating CCNB2 in cancer surveillance.
    Mo ML; Chen Z; Li J; Li HL; Sheng Q; Ma HY; Zhang FX; Hua YW; Zhang X; Sun DQ; Xu ML; Niu RG; Xu JP; Zuo HJ; Liu M; Zhou HM
    Int J Biol Markers; 2010 Nov; 25(4):. PubMed ID: 21110300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gait speed predicts post-operative medical complications in elderly gastric cancer patients undergoing gastrectomy.
    Chandoo A; Chi CH; Ji W; Huang Y; Chen XD; Zhang WT; Wu RS; Shen X
    ANZ J Surg; 2018; 88(7-8):723-726. PubMed ID: 29228514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric cancer with solitary liver metastasis accompanied by cyst formation.
    Urabe M; Yamashita H; Akamatsu N; Seto Y
    ANZ J Surg; 2019 Jun; 89(6):784-785. PubMed ID: 29228511
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening of long non-coding RNAs markers in plasma of children with chronic gastritis.
    Gu Z; Shen HQ; Fu PH; Chen M
    Chronic Dis Transl Med; 2020 Mar; 6(1):62-68. PubMed ID: 32226936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating SHIP2 mRNA as a novel biomarker in the diagnosis and prognosis of gastric cancer.
    Xie JF; Xie NS; Tang JH; Gu QP; Luo QT
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5129-5134. PubMed ID: 29228424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
    Zhang J; Dai WJ; Yang XZ
    Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis.
    Gao Y; Zhang K; Xi H; Cai A; Wu X; Cui J; Li J; Qiao Z; Wei B; Chen L
    Oncotarget; 2017 Jan; 8(4):6330-6340. PubMed ID: 28009985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic and prognostic value of tsRNAs in gastric cancers: a systematic review and meta-analysis.
    Gao H; Zhang Q; Wu W; Gu J; Li J
    Expert Rev Mol Diagn; 2023; 23(11):985-997. PubMed ID: 37649251
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.